latest news releases from the newsroom
Calypso Wireless, Inc.
Sleipner Announces Acquisition by Calypso Wireless to Deliver Calypso Dual Mode WiFi-GSM-GPRS VoIP Smart Cellular Phones in Europe
MILAN, Italy, Oct. 18, 2005 (PRIMEZONE) -- Sleipner S.A., a Milan-based company at the forefront of development and design of software for wireless handheld devices announced today that it has signed an agreement to be acquired by Calypso Wireless, Inc., (Pink Sheets:CLYW) a leader in advanced wireless telecommunications technology. Sleipner's COMOB software enables smart phones and wireless PDA/Pocket PCs to switch between GSM or CDMA cellular towers and WiFi access points (hot spots). Sleipner provides VoIP and IP solutions and applications for the enterprise and vertical markets. The Sleipner software enhances and helps implement the CALYPSO patented ASNAP(tm) technology that allows the seamless switching between cell towers and various access points. The acquisition was made by Calypso to expedite the delivery to market of the Calypso' ASNAP(tm) patented technology on the C1250i WiFi-GSM-GPRS VoIP smart cellular phone. Calypso's C1250i, which runs on Intel (Nasdaq:INTC) PXA series application processor and Microsoft (Nasdaq:MSFT) WinCE 5.0 operating system, has already been successfully demonstrated in field trials.
DSM Acquires Chinese Resins Producer Syntech
HEERLEN, Netherlands, Oct. 18, 2005 (PRIMEZONE) -- Dutch specialty chemicals company Royal DSM N.V. today acquired Syntech, a producer and marketer of coating resins. Syntech has annual sales of around USD 30 million, generated with a broad portfolio of coating resins. The acquisition of Syntech further strengthens DSM's liquid coating resins portfolio and will enable DSM to further accelerate the expansion of its activities in the Chinese market.
Galapagos Expands Its Collaboration With Serono
MECHELEN, Belgium, Oct. 18, 2005 (PRIMEZONE) -- Galapagos (Euronext Brussels: GLPG) (Euronext Amsterdam: GLPGA) announced today that its services division BioFocus has reached agreement with the Swiss pharmaceutical company Serono to supply biologically directed library compounds from its SoftFocus(R) collection throughout 2005-2006 for Serono's emerging drug discovery programs. Furthermore, medicinal chemistry services already being provided by BioFocus will be expanded further to accelerate Serono's existing programs.The unique combination of BioFocus' and Serono's capabilities have proven to be highly fruitful, and it is envisaged that this increased collaboration will lead to further drug discovery programs between the two companies.
Metso Files the Form 20-F/A
HELSINKI, Finland, Oct. 18, 2005 (PRIMEZONE) -- Metso Corporation has yesterday filed with the Securities and Exchange Commission the Form 20-F/A as Amendment No. 1 to its Annual Report on Form 20-F filed on March 30, 2005. The Amendment No. 1 clarifies the previous years' restatements of net income in accordance with U.S. GAAP as stated in our initial 20-F filing in March 2005. Subsequently the "Item 15. Controls and Procedures" has been modified accordingly. The Form 20-F/A is available as a pdf-document on Metso's Internet site at www.metso.com.
Port of Houston Authority
PHA Commission Delivers Bayport and Legislative Consulting Matters
HOUSTON, Oct. 17, 2005 (PRIMEZONE) -- The Port of Houston Authority (PHA) commission approved several recommendations involving contract awards, bids and proposals, professional services and general administrative and operational matters during its public meeting on Monday, Oct. 17, 2005. Additionally, they pulled three items related to the Bayport cruise facility. Chairman Jim Edmonds presided over the meeting with Vice Chairman Kase Lawal, Commissioner Steve Phelps, Commissioner Jim Fonteno, Commissioner Jimmy Burke, Commissioner Cheryl Thompson-Draper, and Commissioner Janiece Longoria.
The Pomerantz Firm Announces Additional Details Relevant to the Securities Fraud Litigation Against Refco, Inc. -- RFX
NEW YORK, Oct. 17, 2005 (PRIMEZONE) -- On October 12, 2005, Pomerantz Haudek Block Grossman & Gross LLP (www.pomerantzlaw.com) filed a class action complaint in the United States District Court, Southern District of New York, on behalf of investors who purchased the common stock of Refco, Inc. ("Refco" or "Company") (NYSE:RFX) between August 11, 2005 and October 7, 2005 ("Class Period"). Refco has now conceded that the Registration Statement that was issued in connection with its August 11, 2005 initial public offering ("IPO") contained false financials and failed to disclose $430 million in uncollectible debts owed to it by a company controlled by its CEO, Chairman and controlling shareholder Philip R. Bennett. Defendants in the case are Refco, Philip R. Bennett, Gerald M. Sherer (Refco's CFO), certain underwriters, and Refco's outside auditors, Grant Thornton LLP. Plaintiff seeks remedies under Sections 11 and 15 of the Securities Act of 1933 and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.